Adicet Bio, Inc.
ACET
12 insider filings · Latest: Apr 27, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | Apr 13 9:20 PM | RA CAPITAL MANAGEMENT, L.P.10% Owner | Purchase | 74,751 | $7.27 | $543.4K | 1,182,624(I) | View → |
| Feb 19, 2026 | Apr 13 9:20 PM | RA CAPITAL MANAGEMENT, L.P.10% Owner | Purchase | 74,268 | $7.21 | $535.5K | 1,107,873(I) | View → |
| Feb 18, 2026 | Apr 13 9:20 PM | RA CAPITAL MANAGEMENT, L.P.10% Owner | Purchase | 74,577 | $7.04 | $525.0K | 1,033,605(I) | View → |
| Apr 8, 2026 | Apr 9 9:38 PM | ORBIMED ADVISORS LLC10% Owner | Sale | 72,939 | $6.42 | $468.1K | 0(I) | View → |
| Apr 7, 2026 | Apr 9 9:38 PM | ORBIMED ADVISORS LLC10% Owner | Sale | 31,719 | $6.52 | $206.8K | 32,523(I) | View → |
| Apr 9, 2026 | Apr 9 9:34 PM | OrbiMed Genesis Master Fund, L.P. | Proposed Sale | 78,499 | $6.55 | $514.2K | — | View → |
| Apr 8, 2026 | Apr 9 12:14 AM | OrbiMed Israel Partners II, L.P. | Proposed Sale | 40,416 | $6.55 | $264.7K | — | View → |
| Apr 7, 2026 | Apr 8 12:46 AM | OrbiMed Israel Partners Limited Partnership | Proposed Sale | 64,242 | $6.43 | $413.1K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | Apr 29 8:15 PM | RA CAPITAL MANAGEMENT, L.P.10% Owner | Other (J) | 250,000 | $0.0001 | 1,402,833(I) | View → |
| Mar 25, 2026 | Mar 27 8:14 PM | Brian Nicholas HarveyChief Financial Officer | Grant/Award | 43,361 | $6.81 | 43,361(D) | View → |
| Mar 25, 2026 | Mar 27 8:12 PM | Chen SchorDirector, President & CEO | Grant/Award | 468,555 | $6.81 | 468,555(D) | View → |
| Mar 25, 2026 | Mar 27 8:10 PM | Julia D. MaltzmanChief Medical Officer | Grant/Award | 72,555 | $6.81 | 72,555(D) | View → |
| Mar 25, 2026 | Mar 27 8:08 PM | Don HealeyChief Technology Officer | Grant/Award | 43,361 | $6.81 | 43,361(D) | View → |
| Mar 25, 2026 | Mar 27 8:05 PM | Blake AftabChief Scientific Officer | Grant/Award | 72,555 | $6.81 | 72,555(D) | View → |